<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="111128">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02137265</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0343</org_study_id>
    <nct_id>NCT02137265</nct_id>
  </id_info>
  <brief_title>Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Trial of Clomiphene Citrate of Clomiphene Citrate in Hypoandrogenism and Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Valenciano de Infertilidad, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <authority>Spain: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Prescribed clomiphene citrate to azoospermic patients with hypoandrogenism could
      improve the sperm retrieval in either fresh sperm or after surgical sperm extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypogonadism (low testosterone level) is frequently observed in men presenting with non
      obstructive azoospermia. Controversy exists regarding the efficacy of preoperative hormonal
      manipulation in patients with  hypogonadism. However, it is possible that hormonal therapy
      increases intra-testicular testosterone levels, and with a rise in serum testosterone, sperm
      production and surgical success with microTESE improve.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Presence of sperm in the ejaculated or in the microsurgical testicular Sperm extraction (microTESE)</measure>
    <time_frame>After four months of clomiphene treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Testosterone levels and Bioavailable Testosterone levels</measure>
    <time_frame>After two weeks and four months with clomiphene treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>6-7 weeks after embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Identification of at least 1 gestational sac with a fetal heartbeat by transvaginal ultrasound examination</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Non Obstructive Azoospermia</condition>
  <condition>Hypogonadism</condition>
  <arm_group>
    <arm_group_label>Clomiphene citrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clomiphene citrate 25 mg every other day during 4-6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo every other day during 4-6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene</intervention_name>
    <description>Clomiphene citrate 50 mg orally every other day</description>
    <arm_group_label>Clomiphene citrate</arm_group_label>
    <other_name>Clomid</other_name>
    <other_name>Serophene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One pill every other day</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years old

          -  Azoospermia confirmed in at least 2 semen analyses with centrifugation.

          -  Testosterone &lt;300 ng/dL and Bioavailable Testosterone&lt;156 ng/dL.

        Exclusion Criteria:

          -  Presence of genetic disorders: Y chromosome deletions or abnormal karyotypes.

          -  Luteinizing hormone (LH) &gt;25 IU/mL.

          -  Estradiol &gt; 40 ng/dL.

          -  Hypogonadotropic hypogonadism  (LH &lt;2 IU/mL and Follicle Stimulating Hormone (FSH) &lt;1
             IU/mL).

          -  Obstructive azoospermia:

          -  FSH &lt;7.6 IU/mL plus testicle longitudinally axis &gt;4.6 cm.

          -  Bilateral absence of vas deferens.

          -  Surgical history of vasectomy.

          -  Clinical varicocele (palpable or visible in physical exam)

          -  Previous history of cryptorchidism.

          -  Use of chemotherapy, testosterone, or anti-androgen in the last two years. Partner
             &gt;40 years or female factor infertility associated.

          -  Contraindications to clomiphene use: depression, heart and liver impairment,
             uncontrolled    thyroid/adrenal dysfunction, organic intracranial lesions.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig Niederberger, MD, FRCS</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Urology, UIC College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luján Satur, MD, PhD</last_name>
    <phone>3129969330</phone>
    <email>satlujan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niederberger Craig, MD, FRCS</last_name>
    <phone>3129969330</phone>
    <email>craignied@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Illinois</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Craig Niederberger, MD, FRCS</last_name>
      <phone>312-996-9330</phone>
      <email>craignied@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Satur Luján, MD, PhD</last_name>
      <phone>3129969330</phone>
      <email>satlujan@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Satur Luján, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl. 2005 Nov-Dec;26(6):787-91; discussion 792-3.</citation>
    <PMID>16291975</PMID>
  </results_reference>
  <results_reference>
    <citation>Hussein A, Ozgok Y, Ross L, Rao P, Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7.</citation>
    <PMID>22958644</PMID>
  </results_reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 12, 2014</lastchanged_date>
  <firstreceived_date>May 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Dr. Craig Niederberger</investigator_full_name>
    <investigator_title>Clarence C. Saelhof Professor and Head, Department of Urology, UIC College of Medicine</investigator_title>
  </responsible_party>
  <keyword>Azoospermia</keyword>
  <keyword>Hypogonadism</keyword>
  <keyword>Clomiphene</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Azoospermia</mesh_term>
    <mesh_term>Hypogonadism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
